Closing not excl. Medicinal product discount association pursuant to § 130a(8) SGB V by means of an open-house model on the active substance testosterone (ATC code according to WHO: G03BA03) Text automatically translated in your browsing language Automatically translated

The subject of this publication is the conclusion of non-exclusive discount agreements pursuant to § 130a(8) SGB V for medicinal products containing the active substance testosterone (ATC code according to WHO: G03BA03), restricted to 1000 mg solution for injection. The contract is concluded within the framework of an open-house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided that they meet and accept the conditions for participation. As a result, individual contract negotiations are not conducted and there is no (delivery) exclusivity. It should be noted that the quantity purchased is unknown, as it depends on the demand and the development of the number of insured persons, on the regulatory behaviour of doctors and on the supply and stockpiling behaviour of public pharmacies. Minimum purchase quantities are therefore not guaranteed. Interested pharmaceutical entrepreneurs can download the participation documents via the project room of the German Public Procurement Portal (DTVP). First of all, an application for access to the project space is required. After activation by the client, the participation documents can then be accessed. The content of the participation documents - in particular the content of the discount agreement and the discounts mentioned therein - must be kept in absolute silence. A complete or partial disclosure or making available of contents of the participation documents to or for third parties requires the prior written consent of the client. If participation is not granted, all documents must be destroyed without undue delay in accordance with data protection regulations. The documents to be submitted are based on the documents "cover letter" and "explanations of the terms of the contract" stored in the project room. Communication, including the transmission of the participation documents, shall be carried out electronically via the DTVP procurement portal; Details can be found in the above-mentioned documents. Any information to the contrary in the contract notice is due for technical reasons and does not claim any liability. Applications for participation can be submitted for the first time until 23.06.2025 for a contract beginning on 01.08.2025. The deadlines for the start of the contract (from 01.09.2025 or later) can be found in the annex "Submission deadlines" deposited in the project room. If the day of submission falls on a Saturday, Sunday or national public holiday, the next working day shall take the place of such a day. In case of late access, the requests to participate submitted will be taken into account for the next submission deadline. The discount agreement ends, regardless of the date of conclusion of the contract, no later than 31.07.2027. The client reserves the right to terminate the open house procedure prematurely, in particular in the case of the conclusion of exclusive discount agreements; in this case, the rebate agreements already concluded shall end in accordance with the contractual provisions. According to the experience of the contracting authority, exclusive discount agreements usually enter into force 8 to 12 months after the publication of the corresponding contract notice in the Supplement to the Official Journal of the European Union. Text automatically translated in your browsing language Automatically translated

33600000 - Pharmaceutical products